Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD

Kristoffer Ostridge, Nicholas Williams, Viktoriya Kim, Michael Bennett, Stephen Harden, Lindsay Welch, Simon Bourne, Ngaire A. Coombs, Paul T. Elkington, Karl J. Staples, Tom M.A. Wilkinson

Research output: Contribution to journalArticle

Abstract

BackgroundMatrix metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extracellular matrix and drive tissue remodelling, key processes in the pathogenesis of COPD. The development of small airway disease has been identified as a critical mechanism in the early development of airflow obstruction but the contribution of MMPs in human disease is poorly characterised.ObjectivesWe investigated the role of MMPs and inflammatory cytokines in the lung by quantifying levels and determining relationships with the key pathological components of COPD in patients and healthy controls.MethodsWe analysed levels of MMPs and inflammatory cytokines in bronchoalveolar lavage from 24 COPD and 8 control subjects. Each subject underwent spirometry and high-resolution CT. Image analysis quantitatively assessed emphysema, bronchial wall thickening and small airways disease.ResultsMultiple MMPs (MMP-1, -2, -3, -8, -9 and -10) and cytokines (interleukin (IL) 6 and IL-8) were elevated in lungs of subjects with COPD. MMP-3, -7, -8, -9, -10 and -12 concentrations closely associated with CT markers of small airways disease. Emphysema severity was also associated with MMP-3, -7 and -10. However, there were no strong relationships between MMPs and bronchial wall thickness of the larger airways.ConclusionsPulmonary MMP concentrations are directly associated with the extent of gas trapping and small airways disease identified on CT scan. This study suggests that MMPs play a significant role in small airways remodelling, a key feature in the pathogenesis of COPD.Trial registration number NCT01701869
Original languageEnglish
Pages (from-to)126-132
Number of pages7
JournalThorax
Volume71
Issue number2
DOIs
Publication statusPublished - Feb 2016

Fingerprint

Emphysema
Matrix Metalloproteinases
Chronic Obstructive Pulmonary Disease
Lung
Cytokines
Airway Remodeling
Spirometry
Metalloproteases
Bronchoalveolar Lavage
Interleukin-8
Extracellular Matrix
Interleukin-6
Peptide Hydrolases
Gases

Cite this

Ostridge, Kristoffer ; Williams, Nicholas ; Kim, Viktoriya ; Bennett, Michael ; Harden, Stephen ; Welch, Lindsay ; Bourne, Simon ; Coombs, Ngaire A. ; Elkington, Paul T. ; Staples, Karl J. ; Wilkinson, Tom M.A. / Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD. In: Thorax. 2016 ; Vol. 71, No. 2. pp. 126-132.
@article{213f99db4fd94a089ab8c06858942bf3,
title = "Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD",
abstract = "BackgroundMatrix metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extracellular matrix and drive tissue remodelling, key processes in the pathogenesis of COPD. The development of small airway disease has been identified as a critical mechanism in the early development of airflow obstruction but the contribution of MMPs in human disease is poorly characterised.ObjectivesWe investigated the role of MMPs and inflammatory cytokines in the lung by quantifying levels and determining relationships with the key pathological components of COPD in patients and healthy controls.MethodsWe analysed levels of MMPs and inflammatory cytokines in bronchoalveolar lavage from 24 COPD and 8 control subjects. Each subject underwent spirometry and high-resolution CT. Image analysis quantitatively assessed emphysema, bronchial wall thickening and small airways disease.ResultsMultiple MMPs (MMP-1, -2, -3, -8, -9 and -10) and cytokines (interleukin (IL) 6 and IL-8) were elevated in lungs of subjects with COPD. MMP-3, -7, -8, -9, -10 and -12 concentrations closely associated with CT markers of small airways disease. Emphysema severity was also associated with MMP-3, -7 and -10. However, there were no strong relationships between MMPs and bronchial wall thickness of the larger airways.ConclusionsPulmonary MMP concentrations are directly associated with the extent of gas trapping and small airways disease identified on CT scan. This study suggests that MMPs play a significant role in small airways remodelling, a key feature in the pathogenesis of COPD.Trial registration number NCT01701869",
author = "Kristoffer Ostridge and Nicholas Williams and Viktoriya Kim and Michael Bennett and Stephen Harden and Lindsay Welch and Simon Bourne and Coombs, {Ngaire A.} and Elkington, {Paul T.} and Staples, {Karl J.} and Wilkinson, {Tom M.A.}",
year = "2016",
month = "2",
doi = "10.1136/thoraxjnl-2015-207428",
language = "English",
volume = "71",
pages = "126--132",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group",
number = "2",

}

Ostridge, K, Williams, N, Kim, V, Bennett, M, Harden, S, Welch, L, Bourne, S, Coombs, NA, Elkington, PT, Staples, KJ & Wilkinson, TMA 2016, 'Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD' Thorax, vol. 71, no. 2, pp. 126-132. https://doi.org/10.1136/thoraxjnl-2015-207428

Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD. / Ostridge, Kristoffer; Williams, Nicholas; Kim, Viktoriya; Bennett, Michael; Harden, Stephen; Welch, Lindsay; Bourne, Simon; Coombs, Ngaire A.; Elkington, Paul T.; Staples, Karl J.; Wilkinson, Tom M.A.

In: Thorax, Vol. 71, No. 2, 02.2016, p. 126-132.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD

AU - Ostridge, Kristoffer

AU - Williams, Nicholas

AU - Kim, Viktoriya

AU - Bennett, Michael

AU - Harden, Stephen

AU - Welch, Lindsay

AU - Bourne, Simon

AU - Coombs, Ngaire A.

AU - Elkington, Paul T.

AU - Staples, Karl J.

AU - Wilkinson, Tom M.A.

PY - 2016/2

Y1 - 2016/2

N2 - BackgroundMatrix metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extracellular matrix and drive tissue remodelling, key processes in the pathogenesis of COPD. The development of small airway disease has been identified as a critical mechanism in the early development of airflow obstruction but the contribution of MMPs in human disease is poorly characterised.ObjectivesWe investigated the role of MMPs and inflammatory cytokines in the lung by quantifying levels and determining relationships with the key pathological components of COPD in patients and healthy controls.MethodsWe analysed levels of MMPs and inflammatory cytokines in bronchoalveolar lavage from 24 COPD and 8 control subjects. Each subject underwent spirometry and high-resolution CT. Image analysis quantitatively assessed emphysema, bronchial wall thickening and small airways disease.ResultsMultiple MMPs (MMP-1, -2, -3, -8, -9 and -10) and cytokines (interleukin (IL) 6 and IL-8) were elevated in lungs of subjects with COPD. MMP-3, -7, -8, -9, -10 and -12 concentrations closely associated with CT markers of small airways disease. Emphysema severity was also associated with MMP-3, -7 and -10. However, there were no strong relationships between MMPs and bronchial wall thickness of the larger airways.ConclusionsPulmonary MMP concentrations are directly associated with the extent of gas trapping and small airways disease identified on CT scan. This study suggests that MMPs play a significant role in small airways remodelling, a key feature in the pathogenesis of COPD.Trial registration number NCT01701869

AB - BackgroundMatrix metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extracellular matrix and drive tissue remodelling, key processes in the pathogenesis of COPD. The development of small airway disease has been identified as a critical mechanism in the early development of airflow obstruction but the contribution of MMPs in human disease is poorly characterised.ObjectivesWe investigated the role of MMPs and inflammatory cytokines in the lung by quantifying levels and determining relationships with the key pathological components of COPD in patients and healthy controls.MethodsWe analysed levels of MMPs and inflammatory cytokines in bronchoalveolar lavage from 24 COPD and 8 control subjects. Each subject underwent spirometry and high-resolution CT. Image analysis quantitatively assessed emphysema, bronchial wall thickening and small airways disease.ResultsMultiple MMPs (MMP-1, -2, -3, -8, -9 and -10) and cytokines (interleukin (IL) 6 and IL-8) were elevated in lungs of subjects with COPD. MMP-3, -7, -8, -9, -10 and -12 concentrations closely associated with CT markers of small airways disease. Emphysema severity was also associated with MMP-3, -7 and -10. However, there were no strong relationships between MMPs and bronchial wall thickness of the larger airways.ConclusionsPulmonary MMP concentrations are directly associated with the extent of gas trapping and small airways disease identified on CT scan. This study suggests that MMPs play a significant role in small airways remodelling, a key feature in the pathogenesis of COPD.Trial registration number NCT01701869

U2 - 10.1136/thoraxjnl-2015-207428

DO - 10.1136/thoraxjnl-2015-207428

M3 - Article

VL - 71

SP - 126

EP - 132

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 2

ER -